8-K current report · filed Nov 5, 2026

Wendy's Co (WEN) 8-K Current Report: November 5, 2026

Item 1.01Item 3.03Item 5.02Item 5.03Item 7.01Item EX-99.1WEN overview

Short answer

Wendy's Co (WEN) filed an 8-K current report with the SEC on November 5, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.03 (Material Modification to Rights of Security Holders), Item 5.02 (Departure/Election of Directors or Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Adoption of one-year poison pill, expiring November 3, 2027, following Trian-led $7.35-per-share unsolicited proposal.

Wendy's Co 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.01 · Entry into a Material Definitive Agreement

  • Adoption of one-year poison pill, expiring November 3, 2027, following Trian-led $7.35-per-share unsolicited proposal
  • 15% ownership threshold, including certain derivatives, triggers substantial dilution for an unapproved acquirer
  • Rights issued for each common share, with $37.00 exercise price for one one-thousandth of preferred share
  • Trian-affiliated directors excluded from approval, highlighting direct conflict between incumbent Board and proposing shareholder group
  • Mechanism raises takeover barriers and gives independent directors time to negotiate, reject, or seek superior alternatives

Item 3.03 · Material Modification to Rights of Security Holders

  • Item 3.03 links security-holder rights changes to Item 1.01’s material agreement disclosure
  • Investor impact depends on the agreement terms described in Item 1.01, not provided here

Item 5.02 · Departure/Election of Directors or Officers

  • Change-in-control protections expanded, removing exclusions for transactions involving Nelson Peltz or Peter W. May
  • Performance units convert to restricted stock units using actual, target, or relative TSR performance outcomes
  • 18-month post-change-in-control protection period for qualifying terminations
  • Good Reason resignations treated like company-initiated terminations for severance and equity vesting
  • Enhanced executive payout obligations could increase acquisition costs and shareholder dilution risk

Item 5.03 · Amendments to Articles of Incorporation or Bylaws

  • New Series A preferred stock designation supporting Wendy’s shareholder rights plan
  • Certificate establishes rights, powers and preferences for preferred shares
  • Delaware filing scheduled for November 5, 2026
  • Rights-plan structure may affect takeover prospects and shareholder voting dynamics

Item 7.01 · Regulation FD Disclosure

  • Wendy’s rejected an unsolicited, non-binding Investor Group proposal to buy remaining shares for $7.35 per share cash
  • Board adopted a Rights Agreement and declared a dividend of shareholder rights, creating a takeover-defense mechanism
  • Proposal rejection preserves standalone strategy but leaves potential acquisition uncertainty for shareholders

Item EX-99.1 · Exhibit EX-99.1

  • Independent Committee rejected Trian-led $7.35-per-share cash proposal, citing substantial undervaluation of Wendy’s standalone prospects
  • Committee backing Dave’s Way strategy, targeting customer traffic, market share and restaurant profitability under CEO Bob Wright
  • One-year shareholder rights plan effective immediately, expiring November 3, 2027
  • Rights trigger at 15% ownership without Board or Committee approval, limiting potential takeover accumulation without a premium
  • Investor Group’s refusal to sign a standstill agreement contributed to adoption of the rights plan

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Wendy's Co 8-K filings

Get the next WEN 8-K as it lands

Follow WEN for push alerts, or ask the research agent what this filing means.